Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vipul Chowdhary
Observed name:
Chowdhary, Vipul
Institution:
Policy Cures
Observed institutions:
Centers for Disease Control and Prevention,
Institut Pasteur,
Policy Cures,
World Health Organization,
World Health Organization Regional Office for the Eastern Mediterranean,
Federal Ministry of Health,
Médecins Sans Frontières
show all 7
ORCID:
0000-0002-6928-4289
Observed ORCID:
0000-0002-6928-4289
OpenAlex ID:
A5031461286
Human Monkeypox Outbreak Caused by Novel Virus Belonging to Congo Basin Clade, Sudan, 2005
2010
·
Pierre Formenty
, Mohammed O. Muntasir
, et al.
·
Emerging infectious diseases
·
205
PDF
Discovery of Monkeypox in Sudan
2006
·
Inger K. Damon
, Cathy E. Roth
, et al.
·
New England Journal of Medicine
·
103
PDF
Phylogenetic and Ecologic Perspectives of a Monkeypox Outbreak, Southern Sudan, 2005
2013
·
Yoshinori Nakazawa
, Ginny L. Emerson
, et al.
·
Emerging infectious diseases
·
86
PDF
Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model
2018
·
Ruth Young
, Tewodros Bekele
, et al.
·
Gates Open Research
·
26
Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model
2018
·
Ruth Young
, Tewodros Bekele
, et al.
·
Gates Open Research
·
24
Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model
2020
·
Ruth Young
, Tewodros Bekele
, et al.
·
Gates Open Research
·
21
Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries
2022
·
Marco Schäferhoff
, Armand Zimmerman
, et al.
·
The Lancet Global Health
·
11
PDF
Analysis of the health product pipeline for poverty-related and neglected diseases using the Portfolio-to-Impact (P2I) modeling tool
2020
·
Shashika Bandara
, Nick Chapman
, et al.
·
F1000Research
·
7
PDF
Developing an Aggregator Mechanism for Late-Stage Clinical Trials of Neglected Disease Product Candidates
2020
·
Gavin Yamey
, Marco Schäferhoff
, et al.
·
SSRN Electronic Journal
·
6
Investing in Late-Stage Clinical Trials and Manufacturing of Neglected Disease Product Candidates – Modeling the Benefits and Costs of Investments for Three Middle-Income Countries
2021
·
Marco Schäferhoff
, Armand Zimmerman
, et al.
·
SSRN Electronic Journal
·
1
Candidates in the pipeline for neglected diseases, as of August 31 2017
2020
·
Young, Ruth
, Bekele, Tewodros
, et al.
·
Figshare
·
1
Adapted P2I tool showing anticipated launches and costs by disease and archtype.
2020
·
Young, Ruth
, Bekele, Tewodros
, et al.
·
Figshare
·
1
Expected launches: unrounded, rounded to nearest integer, and rounded down.
2020
·
Young, Ruth
, Bekele, Tewodros
, et al.
·
Figshare
·
1
Peer Review Report For: Analysis of the health product pipeline for poverty-related and neglected diseases using the Portfolio-to-Impact (P2I) modeling tool [version 1; peer review: 2 approved]
2022
·
Shashika Bandara
, Nick Chapman
, et al.
PDF
Peer Review Report For: Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model [version 2; peer review: 3 approved]
2018
·
Ruth Young
, Tewodros Bekele
, et al.
PDF
Peer Review Report For: Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model [version 2; peer review: 3 approved]
2018
·
Ruth Young
, Tewodros Bekele
, et al.
Peer Review Report For: Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model [version 1; peer review: 1 approved, 2 approved with reservations]
2018
·
Ruth Young
, Tewodros Bekele
, et al.
Peer Review Report For: Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model [version 1; peer review: 1 approved, 2 approved with reservations]
2018
·
Ruth Young
, Tewodros Bekele
, et al.
Peer Review Report For: Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model [version 1; peer review: 1 approved, 2 approved with reservations]
2018
·
Ruth Young
, Tewodros Bekele
, et al.
Show more works
View as search
Works count:
23
Citation count:
494
H-index:
7
I10-index:
7
Year
Topic
Type
